Exodus Point Capital Management, LP Immuneering Corp Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
SELL
$7.21 - $10.68 $49,864 - $73,862
-6,916 Reduced 5.42%
120,803 $928,000
Q2 2023

Aug 10, 2023
BUY
$6.49 - $13.36 $268,828 - $553,397
41,422 Added 48.0%
127,719 $1.3 Million
Q1 2023

May 11, 2023
BUY
$3.78 - $10.38 $326,202 - $895,762
86,297 New
86,297 $838,000

Others Institutions Holding IMRX

# of Institutions
60
Shares Held
9.65M
Call Options Held
0
Put Options Held
0
View Full List

About Immuneering Corp

IMRX Quotes by TradingView
  • Ticker IMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,392,300
  • Market Cap $70.2M
  • Description
  • Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...
More about IMRX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email